共 50 条
- [31] Statistical challenges in the evaluation of surrogate endpoints in randomized trials CONTROLLED CLINICAL TRIALS, 2002, 23 (06): : 607 - 625
- [33] Cancer prevention: biomarkers and surrogate endpoints in clinical trials BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 217 - 232
- [35] Novel Procedures for Validating Surrogate Endpoints in Clinical Trials CURRENT CLINICAL PHARMACOLOGY, 2007, 2 (02): : 123 - 128
- [36] Surrogate endpoints in randomised controlled trials: a reality check LANCET, 2019, 394 (10195): : 281 - 283
- [38] Surrogate endpoints in clinical trials: idols with feet of clay EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2015, 26 (122): : 295 - 301
- [40] The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project ONCOLOGIST, 2017, 22 (12): : 1415 - 1418